Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT07441200 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07441200
Sponsor: NS Pharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2026-07-01
Primary completion: 2028-08-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.